Literature DB >> 17032574

Contingency management interventions for HIV-related behaviors.

Nancy A Haug1, James L Sorensen.   

Abstract

Contingency management (CM) is a scientifically based treatment approach typically employed in substance abuse treatment settings to reinforce drug abstinence, counseling attendance, completion of activities, or other treatment goals. Although the application of CM to HIV management has few published studies, it shows promise as an intervention for HIV-related behaviors. CM interventions such as voucher reinforcement, prize systems, and cash incentives can be used to reduce HIV risk behaviors and to improve HIV medication adherence. CM programs have wide applicability to HIV prevention and management in clinical and community settings and can be implemented as stand-alone techniques or in combination with other interventions.

Entities:  

Mesh:

Year:  2006        PMID: 17032574     DOI: 10.1007/s11904-006-0010-5

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  27 in total

Review 1.  A comprehensive guide to the application of contingency management procedures in clinical settings.

Authors:  N M Petry
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

2.  Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Authors:  K M Carroll; S A Ball; C Nich; P G O'Connor; D A Eagan; T L Frankforter; E G Triffleman; J Shi; B J Rounsaville
Journal:  Arch Gen Psychiatry       Date:  2001-08

3.  Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up.

Authors:  David H Epstein; Wesley E Hawkins; Lino Covi; Annie Umbricht; Kenzie L Preston
Journal:  Psychol Addict Behav       Date:  2003-03

4.  The effect of financial incentives on adherence with outpatient human immunodeficiency virus testing referrals from the emergency department.

Authors:  Jason S Haukoos; Mallory D Witt; Clinton J Coil; Roger J Lewis
Journal:  Acad Emerg Med       Date:  2005-07       Impact factor: 3.451

5.  Changes in HIV risk behaviors among patients receiving combined pharmacological and behavioral interventions for heroin and cocaine dependence.

Authors:  Jennifer R Schroeder; David H Epstein; Annie Umbricht; Kenzie L Preston
Journal:  Addict Behav       Date:  2005-08-08       Impact factor: 3.913

6.  Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.

Authors:  Steven Shoptaw; Cathy J Reback; James A Peck; Xiaowei Yang; Erin Rotheram-Fuller; Sherry Larkins; Rosemary C Veniegas; Thomas E Freese; Christopher Hucks-Ortiz
Journal:  Drug Alcohol Depend       Date:  2004-11-28       Impact factor: 4.492

7.  An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar.

Authors:  J M Roll; S T Higgins; G J Badger
Journal:  J Appl Behav Anal       Date:  1996

8.  Increasing opiate abstinence through voucher-based reinforcement therapy.

Authors:  K Silverman; C J Wong; S T Higgins; R K Brooner; I D Montoya; C Contoreggi; A Umbricht-Schneiter; C R Schuster; K L Preston
Journal:  Drug Alcohol Depend       Date:  1996-06       Impact factor: 4.492

9.  Impact of monetary incentives on adherence to referral for screening chest x-rays after syringe exchange-based tuberculin skin testing.

Authors:  David C Perlman; Patricia Friedmann; Leslie Horn; Anne Nugent; Veronika Schoeb; Jeanne Carey; Nadim Salomon; Don C Des Jarlais
Journal:  J Urban Health       Date:  2003-09       Impact factor: 3.671

10.  A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users.

Authors:  Karen H Seal; Alex H Kral; Jennifer Lorvick; Alex McNees; Lauren Gee; Brian R Edlin
Journal:  Drug Alcohol Depend       Date:  2003-08-20       Impact factor: 4.492

View more
  17 in total

Review 1.  Contingency Management Interventions for HIV, Tuberculosis, and Hepatitis Control Among Individuals With Substance Use Disorders: A Systematized Review.

Authors:  Evan S Herrmann; Alexis K Matusiewicz; Maxine L Stitzer; Stephen T Higgins; Stacey C Sigmon; Sarah H Heil
Journal:  J Subst Abuse Treat       Date:  2016-06-24

2.  Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.

Authors:  Lisa R Metsch; Daniel J Feaster; Lauren Gooden; Tim Matheson; Maxine Stitzer; Moupali Das; Mamta K Jain; Allan E Rodriguez; Wendy S Armstrong; Gregory M Lucas; Ank E Nijhawan; Mari-Lynn Drainoni; Patricia Herrera; Pamela Vergara-Rodriguez; Jeffrey M Jacobson; Michael J Mugavero; Meg Sullivan; Eric S Daar; Deborah K McMahon; David C Ferris; Robert Lindblad; Paul VanVeldhuisen; Neal Oden; Pedro C Castellón; Susan Tross; Louise F Haynes; Antoine Douaihy; James L Sorensen; David S Metzger; Raul N Mandler; Grant N Colfax; Carlos del Rio
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

3.  Addressing the Achilles' heel in the HIV care continuum for the success of a test-and-treat strategy to achieve an AIDS-free generation.

Authors:  Jean B Nachega; Olalekan A Uthman; Carlos del Rio; Michael J Mugavero; Helen Rees; Edward J Mills
Journal:  Clin Infect Dis       Date:  2014-07       Impact factor: 9.079

4.  A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.

Authors:  Marcella Alsan; John Beshears; Wendy S Armstrong; James J Choi; Brigitte C Madrian; Minh Ly T Nguyen; Carlos Del Rio; David Laibson; Vincent C Marconi
Journal:  AIDS       Date:  2017-07-31       Impact factor: 4.177

5.  Punto Seguro: A Randomized Controlled Pilot Using Conditional Economic Incentives to Reduce Sexually Transmitted Infection Risks in Mexico.

Authors:  Omar Galárraga; Sandra G Sosa-Rubí; Caroline Kuo; Pedro Gozalo; Andrea González; Biani Saavedra; Nathalie Gras-Allain; Carlos J Conde-Glez; Maria Olamendi-Portugal; Kenneth H Mayer; Don Operario
Journal:  AIDS Behav       Date:  2017-12

Review 6.  Conditional economic incentives to improve HIV treatment adherence: literature review and theoretical considerations.

Authors:  Omar Galárraga; Becky L Genberg; Rosemarie A Martin; M Barton Laws; Ira B Wilson
Journal:  AIDS Behav       Date:  2013-09

7.  Contingency management reduces injection-related HIV risk behaviors in heroin and cocaine using outpatients.

Authors:  Udi E Ghitza; David H Epstein; Kenzie L Preston
Journal:  Addict Behav       Date:  2007-11-17       Impact factor: 3.913

8.  Abstinence-reinforcing contingency management improves HIV viral load suppression among HIV-infected people who use drugs: A randomized controlled trial.

Authors:  Chinazo O Cunningham; Julia H Arnsten; Chenshu Zhang; Moonseong Heo; Marcus A Bachhuber; John J Jost; Robert Grossberg; Melissa R Stein; Nancy L Sohler
Journal:  Drug Alcohol Depend       Date:  2020-08-11       Impact factor: 4.492

Review 9.  Incentivizing HIV/STI testing: a systematic review of the literature.

Authors:  Ramon Lee; Rosa R Cui; Kathryn E Muessig; Harsha Thirumurthy; Joseph D Tucker
Journal:  AIDS Behav       Date:  2014-05

10.  Strategies for promoting adherence to antiretroviral therapy: a review of the literature.

Authors:  Jane M Simoni; K Rivet Amico; Cynthia R Pearson; Robert Malow
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.